News & Updates

Lotilaner drops proven safe, effective in Demodex blepharitis

15 Oct 2023 by

Treatment with lotilaner ophthalmic solution 0.25% twice daily for 6 weeks is well tolerated by patients with Demodex blepharitis and has no serious adverse effects compared to a vehicle control, according to a study. Moreover, use of this drop results in clinically meaningful outcomes.

Lotilaner drops proven safe, effective in Demodex blepharitis

15 Oct 2023

Weight-loss surgery not a risk factor for diabetic retinopathy

30 Sep 2023 by

For people with type 2 diabetes (T2D) and diabetic retinopathy (DR), bariatric surgery does not appear to confer any risk of DR progression, according to a study.

Weight-loss surgery not a risk factor for diabetic retinopathy

30 Sep 2023

Morning BP surge predicts visual field progression in glaucoma patients with hypertension

28 Sep 2023

Normal-tension glaucoma (NTG) patients with hypertension who experience morning blood pressure (BP) surge are likely to have visual field progression, as shown in a study.

Morning BP surge predicts visual field progression in glaucoma patients with hypertension

28 Sep 2023

Calcium-channel blocker use ups glaucoma prevalence

26 Sep 2023 by

Use of calcium-channel blockers (CCBs) appears to increase the risk of developing glaucoma, suggests a study. In addition, use of systemic beta blockers is associated with lower intraocular pressure (IOP).

Calcium-channel blocker use ups glaucoma prevalence

26 Sep 2023

Childhood myopia rate hits record high in Hong Kong

25 Sep 2023 by

Myopia prevalence in school-age children has reached record high in Hong Kong and may remain high over the next few years, a cross-sectional study by researchers from the Chinese University of Hong Kong (CUHK) has found.

Childhood myopia rate hits record high in Hong Kong

25 Sep 2023

Several factors must be considered when tapering adalimumab in noninfectious uveitis patients

24 Sep 2023

For patients who undergo adalimumab tapering after achieving remission, factors such as age, race, and duration of disease remission on adalimumab appear to impact the risk of relapse, according to a study.

Several factors must be considered when tapering adalimumab in noninfectious uveitis patients

24 Sep 2023

Common antihypertensive drug linked to glaucoma

15 Sep 2023 by

The use of calcium channel blockers (CCBs) may contribute to an increased risk of glaucoma despite CCBs having no effect on intraocular pressure (IOP), according to a large study.

Common antihypertensive drug linked to glaucoma

15 Sep 2023

Smoking tied to severe, frequent ocular symptoms in young people

11 Sep 2023

Among teens and young adults, users of both e-cigarettes and cigarettes are more likely to experience severe and frequent ocular symptoms than abstainers, as reported in a study.

Smoking tied to severe, frequent ocular symptoms in young people

11 Sep 2023

Can retinal thinning predict disability in MS?

07 Sep 2023 by

Retinal thinning predicts disability in patients newly diagnosed with relapsing multiple sclerosis (MS), an immune-mediated disease affecting the brain and spinal cord, in a new study presented at EAN 2023.

Can retinal thinning predict disability in MS?

07 Sep 2023

Brolucizumab prolongs interval of anti-VEGF injections in nAMD patients

01 Sep 2023

Treatment with brolucizumab results in a longer interval between injections of antivascular endothelial growth factor (anti-VEGF) agents for most treatment-experienced eyes, especially those with shorter intervals before switching, while maintaining or improving visual acuity (VA), reports a study.

Brolucizumab prolongs interval of anti-VEGF injections in nAMD patients

01 Sep 2023

News & Updates

Filter by Specialty:

Specialty:

Lotilaner drops proven safe, effective in Demodex blepharitis

Lotilaner drops proven safe, effective in Demodex blepharitis

Weight-loss surgery not a risk factor for diabetic retinopathy

Weight-loss surgery not a risk factor for diabetic retinopathy

Morning BP surge predicts visual field progression in glaucoma patients with hypertension

Morning BP surge predicts visual field progression in glaucoma patients with hypertension

Calcium-channel blocker use ups glaucoma prevalence

Calcium-channel blocker use ups glaucoma prevalence

Childhood myopia rate hits record high in Hong Kong

Childhood myopia rate hits record high in Hong Kong

Several factors must be considered when tapering adalimumab in noninfectious uveitis patients

Several factors must be considered when tapering adalimumab in noninfectious uveitis patients

Common antihypertensive drug linked to glaucoma

Common antihypertensive drug linked to glaucoma

Smoking tied to severe, frequent ocular symptoms in young people

Smoking tied to severe, frequent ocular symptoms in young people

Can retinal thinning predict disability in MS?

Can retinal thinning predict disability in MS?

Brolucizumab prolongs interval of anti-VEGF injections in nAMD patients

Brolucizumab prolongs interval of anti-VEGF injections in nAMD patients